Finance

Lists
0A9W:LON
Organon & Co
$13.74
+0.07%
(+0.010) 1D
Oct 7, 5:51:40 PM GMT+1  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 0A9W...
Open
$13.73
High
$13.74
Low
$13.72
Mkt. cap
3.62B
Avg. vol.
3.74K
Volume
161.00
52-wk high
$13.82
52-wk low
$5.72
No. of employees
10K
Open
$13.73
High
$13.74
Low
$13.72
Mkt. cap
3.62B
Avg. vol.
3.74K
Volume
161.00
52-wk high
$13.82
52-wk low
$5.72
No. of employees
10K
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.60B
1.51B
1.46B
1.56B
Cost of goods sold
733.00M
741.00M
670.00M
711.00M
Cost of revenue
733.00M
741.00M
670.00M
711.00M
Research and development expenses
84.00M
91.00M
93.00M
90.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415.00M
431.00M
424.00M
434.00M
Operating expense
499.00M
522.00M
517.00M
524.00M
Total operating expenses
1.23B
1.26B
1.19B
1.24B
Operating income
370.00M
244.00M
273.00M
323.00M
Other non operating income
30.00M
-18.00M
15.00M
-3.00M
EBT including unusual items
243.00M
-148.00M
213.00M
183.00M
EBT excluding unusual items
255.00M
103.00M
170.00M
210.00M
Income tax expense
83.00M
57.00M
67.00M
75.00M
Effective tax rate
34.16%
-38.51%
31.46%
40.98%
Other operating expenses
-
-
-
-
Net income
160.00M
-205.00M
146.00M
108.00M
Net profit margin
9.99%
-13.60%
10.00%
6.93%
Earnings per share
1.01
0.63
0.71
0.85
Interest and investment income
-
-
-
-
Interest expense
-128.00M
-121.00M
-111.00M
-108.00M
Net interest expenses
-128.00M
-121.00M
-111.00M
-108.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
462.00M
340.00M
359.00M
403.00M
Gain or loss from assets sale
-
-
-81.00M
-
AI content may include mistakes. Learn more
Google apps